Notice of Privacy Incident
Medicaid Provider Termination Alert: Revalidation deadlines are approaching. Failure by providers to revalidate will lead to termination and payment suspension. Check your account now at https://impact.illinois.gov/ to learn if your required revalidation is due this month. More revalidation information here.

Drugs and Therapeutics (D & T) Committee Meeting Results for: June 19, 2013

Drug Name	Review Type	Committee Recommendation	Prior Approval Status � Final Determination
Invokana	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Pertzye	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Vascepa	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Myrbetriq	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Tecfidera	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Nesina	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Diclegis	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Tradjenta	New Drug Appeal	Require Prior Approval	Prior Approval Required
Tudorza Pressair	New Drug Appeal	Require Prior Approval	Prior Approval Required
Stribild	New Drug Appeal	Require Prior Approval	Prior Approval Required
Humatrope	PDL Appeal	Require Prior Approval	Prior Approval Required

Footer